Xiangpan Li
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors (NCT05760196) | Xiangpan Li | 2022-10-01 |
Track Xiangpan Li automatically
Every clearance here is in the API, with alerts when new ones post.